CN106261442A - 一种具有保健功能的苦荞可可固体饮料及其制备方法 - Google Patents
一种具有保健功能的苦荞可可固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN106261442A CN106261442A CN201610848409.8A CN201610848409A CN106261442A CN 106261442 A CN106261442 A CN 106261442A CN 201610848409 A CN201610848409 A CN 201610848409A CN 106261442 A CN106261442 A CN 106261442A
- Authority
- CN
- China
- Prior art keywords
- powder
- radix
- rhizoma fagopyri
- fagopyri tatarici
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000009470 Theobroma cacao Nutrition 0.000 title claims abstract description 50
- 235000013361 beverage Nutrition 0.000 title claims abstract description 43
- 239000007787 solid Substances 0.000 title claims abstract description 38
- 230000036541 health Effects 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 244000240602 cacao Species 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 151
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 53
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 30
- 235000013336 milk Nutrition 0.000 claims abstract description 22
- 239000008267 milk Substances 0.000 claims abstract description 22
- 210000004080 milk Anatomy 0.000 claims abstract description 22
- 229940088594 vitamin Drugs 0.000 claims abstract description 20
- 229930003231 vitamin Natural products 0.000 claims abstract description 20
- 235000013343 vitamin Nutrition 0.000 claims abstract description 20
- 239000011782 vitamin Substances 0.000 claims abstract description 20
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 20
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 17
- 239000011707 mineral Substances 0.000 claims abstract description 17
- 239000000654 additive Substances 0.000 claims abstract description 15
- 230000000996 additive effect Effects 0.000 claims abstract description 15
- 235000000346 sugar Nutrition 0.000 claims abstract description 15
- 239000013589 supplement Substances 0.000 claims abstract description 13
- 239000001692 EU approved anti-caking agent Substances 0.000 claims abstract description 11
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 10
- 235000013599 spices Nutrition 0.000 claims abstract description 10
- 235000019197 fats Nutrition 0.000 claims description 23
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 16
- 229940067606 lecithin Drugs 0.000 claims description 16
- 239000000787 lecithin Substances 0.000 claims description 16
- 235000010445 lecithin Nutrition 0.000 claims description 16
- 235000010755 mineral Nutrition 0.000 claims description 16
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 15
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 15
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 15
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 15
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 15
- 235000002378 plant sterols Nutrition 0.000 claims description 15
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 claims description 14
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 239000004376 Sucralose Substances 0.000 claims description 11
- 235000019408 sucralose Nutrition 0.000 claims description 11
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 11
- 235000013312 flour Nutrition 0.000 claims description 10
- 235000003599 food sweetener Nutrition 0.000 claims description 10
- 239000003765 sweetening agent Substances 0.000 claims description 10
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 9
- 229960004488 linolenic acid Drugs 0.000 claims description 9
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 8
- 239000004386 Erythritol Substances 0.000 claims description 8
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 8
- 239000001506 calcium phosphate Substances 0.000 claims description 8
- 229940108924 conjugated linoleic acid Drugs 0.000 claims description 8
- 235000019414 erythritol Nutrition 0.000 claims description 8
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 8
- 229940009714 erythritol Drugs 0.000 claims description 8
- 125000005456 glyceride group Chemical group 0.000 claims description 8
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 8
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 8
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 8
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 8
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 8
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical group COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 8
- 235000012141 vanillin Nutrition 0.000 claims description 8
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims description 8
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- -1 alcohol ester Chemical class 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 6
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 4
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 4
- 235000011201 Ginkgo Nutrition 0.000 claims description 4
- 244000194101 Ginkgo biloba Species 0.000 claims description 4
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 4
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 4
- 235000021014 blueberries Nutrition 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 4
- 239000003094 microcapsule Substances 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 4
- 229940013618 stevioside Drugs 0.000 claims description 4
- 235000019202 steviosides Nutrition 0.000 claims description 4
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- 244000130270 Fagopyrum tataricum Species 0.000 claims description 3
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 150000005846 sugar alcohols Chemical class 0.000 claims description 3
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 claims description 2
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical compound O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004377 Alitame Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000001512 FEMA 4601 Substances 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 241000222336 Ganoderma Species 0.000 claims description 2
- 239000004378 Glycyrrhizin Substances 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 241001090156 Huperzia serrata Species 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 240000000759 Lepidium meyenii Species 0.000 claims description 2
- 235000000421 Lepidium meyenii Nutrition 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 2
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 2
- 244000182216 Mimusops elengi Species 0.000 claims description 2
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- 239000004384 Neotame Substances 0.000 claims description 2
- 240000007817 Olea europaea Species 0.000 claims description 2
- 235000002725 Olea europaea Nutrition 0.000 claims description 2
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 2
- 241000180649 Panax notoginseng Species 0.000 claims description 2
- 235000004347 Perilla Nutrition 0.000 claims description 2
- 244000124853 Perilla frutescens Species 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 claims description 2
- 235000016998 Ribes burejense Nutrition 0.000 claims description 2
- 241000735566 Ribes burejense Species 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 2
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 229930003779 Vitamin B12 Natural products 0.000 claims description 2
- 229930003471 Vitamin B2 Natural products 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 235000019409 alitame Nutrition 0.000 claims description 2
- 108010009985 alitame Proteins 0.000 claims description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- 239000011651 chromium Substances 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 229940109275 cyclamate Drugs 0.000 claims description 2
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims description 2
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 235000012902 lepidium meyenii Nutrition 0.000 claims description 2
- 235000019136 lipoic acid Nutrition 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229930189775 mogroside Natural products 0.000 claims description 2
- 229910052750 molybdenum Inorganic materials 0.000 claims description 2
- 239000011733 molybdenum Substances 0.000 claims description 2
- 235000019412 neotame Nutrition 0.000 claims description 2
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 2
- 108010070257 neotame Proteins 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- 229940055726 pantothenic acid Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- 125000001095 phosphatidyl group Chemical group 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 235000019175 phylloquinone Nutrition 0.000 claims description 2
- 239000011772 phylloquinone Substances 0.000 claims description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 2
- 229960001898 phytomenadione Drugs 0.000 claims description 2
- 229920000223 polyglycerol Polymers 0.000 claims description 2
- 235000007686 potassium Nutrition 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 235000008476 powdered milk Nutrition 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 2
- 235000019203 rebaudioside A Nutrition 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- 229940085605 saccharin sodium Drugs 0.000 claims description 2
- 239000011669 selenium Substances 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 235000012239 silicon dioxide Nutrition 0.000 claims description 2
- 235000010413 sodium alginate Nutrition 0.000 claims description 2
- 239000000661 sodium alginate Substances 0.000 claims description 2
- 229940005550 sodium alginate Drugs 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 125000000185 sucrose group Chemical group 0.000 claims description 2
- 239000011721 thiamine Substances 0.000 claims description 2
- 235000019157 thiamine Nutrition 0.000 claims description 2
- 229960002663 thioctic acid Drugs 0.000 claims description 2
- 229910052720 vanadium Inorganic materials 0.000 claims description 2
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000019163 vitamin B12 Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 235000019164 vitamin B2 Nutrition 0.000 claims description 2
- 239000011716 vitamin B2 Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 235000005282 vitamin D3 Nutrition 0.000 claims description 2
- 239000011647 vitamin D3 Substances 0.000 claims description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- 229940021056 vitamin d3 Drugs 0.000 claims description 2
- 235000008939 whole milk Nutrition 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 235000019441 ethanol Nutrition 0.000 claims 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 241001076416 Dendrobium tosaense Species 0.000 claims 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 235000010358 acesulfame potassium Nutrition 0.000 claims 1
- 229960004998 acesulfame potassium Drugs 0.000 claims 1
- 239000000619 acesulfame-K Substances 0.000 claims 1
- 235000010418 carrageenan Nutrition 0.000 claims 1
- 239000000679 carrageenan Substances 0.000 claims 1
- 229920001525 carrageenan Polymers 0.000 claims 1
- 229940113118 carrageenan Drugs 0.000 claims 1
- 235000012661 lycopene Nutrition 0.000 claims 1
- 229960004999 lycopene Drugs 0.000 claims 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims 1
- 239000001751 lycopene Substances 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims 1
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 1
- 235000019158 vitamin B6 Nutrition 0.000 claims 1
- 239000011726 vitamin B6 Substances 0.000 claims 1
- 229940011671 vitamin b6 Drugs 0.000 claims 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 27
- 239000008280 blood Substances 0.000 abstract description 27
- 230000036772 blood pressure Effects 0.000 abstract description 16
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 208000024827 Alzheimer disease Diseases 0.000 abstract description 7
- 230000033228 biological regulation Effects 0.000 abstract description 7
- 230000001149 cognitive effect Effects 0.000 abstract description 7
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 6
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 4
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 abstract description 3
- 230000000118 anti-neoplastic effect Effects 0.000 abstract description 3
- 239000003925 fat Substances 0.000 description 21
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 18
- 210000004556 brain Anatomy 0.000 description 17
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 14
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 230000006870 function Effects 0.000 description 10
- 235000012000 cholesterol Nutrition 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 230000001629 suppression Effects 0.000 description 8
- 239000011812 mixed powder Substances 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 210000004958 brain cell Anatomy 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 235000019219 chocolate Nutrition 0.000 description 4
- 230000004224 protection Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000000412 Avitaminosis Diseases 0.000 description 2
- 206010021135 Hypovitaminosis Diseases 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 2
- 229960002733 gamolenic acid Drugs 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 208000030401 vitamin deficiency disease Diseases 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 241001480055 Quercus mongolica Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003113 alkalizing effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000002201 avitaminosis Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 201000001514 prostate carcinoma Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 210000004895 subcellular structure Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000009461 vacuum packaging Methods 0.000 description 1
- 230000003845 vascular endothelial function Effects 0.000 description 1
- 230000006438 vascular health Effects 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- OIWCYIUQAVBPGV-DAQGAKHBSA-N {1-O-hexadecanoyl-2-O-[(Z)-octadec-9-enoyl]-sn-glycero-3-phospho}serine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC OIWCYIUQAVBPGV-DAQGAKHBSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/62—Clouding agents; Agents to improve the cloud-stability
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明提供了一种具有保健功能的苦荞可可固体饮料及其制备方法,所述饮料主要用苦荞粉、可可粉、奶粉、甜味剂、抗结剂、乳化剂、矿物质、维生素、营养添加剂、其他补充剂和食用香精香料制成。制成的饮料具有降血糖、降血脂、调节血压、清除超氧自由基、抗氧化、提高记忆力、认知力、学习能力、提高免疫力、抗肿瘤的功效。可用于防治心血管疾病、糖尿病、老年性痴呆等症。
Description
技术领域
本发明涉及一种保健饮料及其制备方法,特别是一种巧克力味的、低糖的、具有保健功能的苦荞可可固体饮料及其制备方法。
背景技术
随着物质生活的丰富、随着人口的老龄化,患高血压、高血脂、高血糖的人越来越多,患糖尿病、心血管疾病、中风的人越来越多。随着年龄的增长,卵磷脂、二十二碳六烯酸、磷脂酰丝氨酸和其他重要的脑内化学物质会逐渐减少,从而导致记忆力、认知力和学习能力减退。因此,迫切需要一种有助于降血糖、降血脂、调节血压,提高记忆力、认知力,学习力,防治老年性痴呆的食品改善身体的健康。
苦荞富含天然黄酮,特别是富含芦丁、槲皮素。芦丁具有清除自由基、抑制生物膜上多不饱和脂肪酸的过氧化,保护生物膜及亚细胞结构的完整性、抗脂质过氧化、抑制高密度脂蛋白氧化修饰,起到抗动脉粥样硬化作用,芦丁还具有血管舒张、降低血管通透性和脆性、促进细胞增生和防治血细胞凝聚、降血糖、抗癌、抗病毒、抑菌、抗炎、镇痛等的作用。槲皮素具有抑制细胞膜脂质的过氧化、清除自由基,保护细胞膜不受过氧化作用的破坏、抑制血小板聚集,选择性的与血管壁上的血栓结合,起到抗血栓形成的作用。槲皮素还具有抗炎、抗病毒、抗肿瘤、保护心血管、和维持血糖稳定等的作用。苦荞黄酮还可以预防及治疗感染、糖尿病、肿瘤及自身免疫病等。
可可富含天然黄烷醇,可可黄烷醇能够改善血管内皮功能、增加可利用的一氧化碳、减少血小板活性、调节炎症信号、减轻氧化损伤,维持血管健康,保持正常的血压,降低血液中血小板的黏附性并维持血流的健康。苦荞和可可结合具有降血糖、降血脂、调节血压、清除超氧自由基、抗氧化、防治心血管疾病、防癌、抗癌、抗衰老、抗病毒、抑菌、抗炎、镇痛等协同作用。
卵磷脂能促使人体大脑中的乙酞胆碱增加,人体大脑乙酞胆碱含量增加能使大脑神经触突迅速发达,加强大脑神经细胞活性,增强记忆力。卵磷脂有利于增加细胞膜的流动性,增加脂肪酸的不饱和度,减少游离脂肪酸,保护生物膜免受自由基损伤、延缓细胞衰老,有助于防止老年痴呆。卵磷脂具有良好的乳化特性,能阻止胆固醇沉积并能清除沉积物,预防心血管病的发生。卵磷脂可降低血清胆固醇的含量,促进脂肪乳化成细小的微粒经血液输送出肝脏,防止脂肪肝和肝硬化。
二十二碳六烯酸是一种对人体非常重要的不饱和脂肪酸,属于ω-3不饱和脂肪酸。二十二碳六烯酸是大脑和视网膜的重要构成成分,是神经系统细胞生长及维持的一种主要成分,在大脑皮质中,二十二碳六烯酸不仅是神经传导细胞的主要成份,也是细胞膜形成的主要成份,对智力和视力发育至关重要。二十二碳六烯酸可以提高生物膜的生理机能,有利于增强神经信息的传递,增强脑和神经系统的活性,对维持脑的功能,维持脑的衰老起着重要作用。二十二碳六烯酸能够促使大脑对磷脂酰丝氨酸的吸收,协同磷脂酰丝氨酸保护神经细胞及改善大脑信号传导功能。二十二碳六烯酸可以降低血清中甘油三酯生成及从肝脏排出,降低低密度脂蛋白、极低密度脂蛋白、增加高密度脂蛋白,改变脂蛋白中脂肪酸的组成,从而增加其流动性;增加胆固醇的排泄,抑制内源性胆固醇的合成。因此二十二碳六烯酸可以降血脂、降血压、降胆固醇,抑制血小板凝聚,减少血栓形成,可以预防和治疗动脉硬化可以预防和治疗高血压、心血管疾病。
二十碳五烯酸能抑制血小板凝聚,抑制甘油三酯合成,具有抗血栓功能,因而具有降血脂的作用,二十碳五烯酸能提高机体免疫力、抗炎及抑制肿瘤细胞增殖等功能。
磷脂酰丝氨酸是脑内重要的化学物质,是脑部神经的主要成分之一,磷脂酰丝氨酸能增加脑突刺数目、增强脑细胞膜的流动性以及促进脑细胞中葡萄糖代谢,从而使脑细胞更活跃。磷脂丝氨酸具有营养和活化脑中各种酶的活性,可延缓神经递质的减少进程,有助于修复、更新大脑受损细胞和清除有害物质。磷脂酰丝氨酸能缓解脑部疲劳、促进注意力集中、提高警觉性和记忆力。磷脂酰丝氨酸可以防治老年人因年龄增长而导致记忆能力和认知能力的下降引发的痴呆等。
共轭亚油酸具有抗肿瘤、抗氧化、降低人体胆固醇、抗动脉粥样硬化、减肥、提高免疫力和提高骨密度功能。
亚麻酸,α-亚麻酸具有抗炎症、抗血栓、抗血凝、抗心率失常、抗癌、降低血脂血压、改善血管弹性的作用,还具有调节中央神经系统、提高记忆力的功能。γ-亚麻酸具有恢复糖尿病患者被损伤的神经细胞、降低血清胆固醇和甘油三酯水平并抑制体内血小板的凝集功能。
植物甾醇能够抑制人体对胆固醇的吸收、促进胆固醇的降解代谢、抑制胆固醇的生化合成、预防治疗冠状动脉粥样硬化、增强毛细血管循环、抗炎、抑制肿瘤、防治前列腺肥大、抑制乳腺增生和调节免疫等的作用,植物甾醇还可以降低乳腺癌、卵巢癌、前列腺癌、结肠癌、肺癌和胃癌的发病危险。
乙酰左旋肉碱和左旋肉碱都具有燃烧体内多余脂肪作为能量从而减少体内脂肪起到减肥的作用,左旋肉碱还具有抗心机缺血、抗心律失常、降血脂、抗疲劳等功能。乙酰左旋肉碱可以穿过血脑障壁,提供脑细胞足够的能量、活化脑细胞的讯息传导、提高学习力、记忆力、认知力,防治老年性的痴呆,还可以增加精子的活性,提高受孕率。
所以合理补充卵磷脂、二十二碳六烯酸、二十碳五烯酸、磷脂酰丝氨酸、α-亚麻酸、共轭亚油酸、植物甾醇和乙酰左旋肉碱能预防心血管疾病的发生、提高学习力、记忆力、认知力,防治老年性痴呆等。
维生素是维护身体健康、促进生长发育和调节生理功能所必须的营养物质,各种维生素之间具有相互合作的特性,彼此相互搭配能够提高各自的功效。维生素在人体内不能合成或合成较少,维生素缺乏可引起维生素缺乏症。微量元素对机体内环境及其生理平衡起重要作用,微量元素不足或过量或元素间比例失调,会对机体产生不利的影响,必须微量元素的缺乏,将导致机体中与该元素密切相关的生物活性物质的缺乏,造成生理功能障碍,甚至导致某些疾病的发生,加速机体衰老。在食物中摄取的维生素和微量元素不均匀甚至有缺失,所以必须合理补充维生素和微量元素。
以往,补充卵磷脂、二十二碳六烯酸、二十碳五烯酸、磷脂酰丝氨酸、α-亚麻酸、共轭亚油酸、植物甾醇或乙酰左旋肉碱时主要吃进口软胶囊,它们价高,不好吃,并且吃了这样又吃那样很不方便,有时甚至记不清楚那种吃了那种没有吃,并且认真吃保健品防治病症的人并不是很多。现在,市面上已经有许多国产卵磷脂、二十二碳六烯酸、二十碳五烯酸、磷脂酰丝氨酸、α-亚麻酸、共轭亚油酸、植物甾醇或乙酰左旋肉碱等微胶囊粉,它们性能更稳定,比进口软胶囊便宜。但是,它们怎么吃,吃那些,吃多少,很麻烦。因此,需要有一种载体能够将它们合理的搭配制成可口的具有保健功能的食品,已便能使更多的人通过补充这些营养物质保持身体健康。
发明内容
本发明的目的在于,提供一种巧克力味的、低糖的、具有保健功能的苦荞可可固体饮料及其制备方法,所述饮料具有降血糖、降血脂、调节血压、清除超氧自由基、抗氧化、提高记忆力、认知力、学习能力、提高免疫力、抗肿瘤的功效。可用于防治心血管疾病、糖尿病、老年性痴呆等症。
为解决上述技术问题,本发明采用以下技术方案实现:
一种具有保健功能的苦荞可可固体饮料,按照重量份计算,用苦荞粉20-60份、可可粉10-50份、奶粉0-30份、一般甜味剂10-50份、高倍甜味剂0.01-5份、抗结剂0.5-4份、乳化剂0.05-7份、矿物质0.1-2份、维生素0.2-1.5份、营养添加剂1-13份、其他补充剂0-8份和食用香精香料0.01-0.1份制成。
前述的具有保健功能的苦荞可可固体饮料中,按重量份计算,用苦荞粉30-50份、可可粉10-40份、奶粉0-20份、一般甜味剂10-50份、高倍甜味剂0.01-3份、抗结剂1-3份、乳化剂0.05-4份、矿物质0.3-1.5份、维生素0.2-1.0份、营养添加剂1-11份、其他补充剂0-7份和食用香精香料0.03-0.07份制成。
前述的具有保健功能的苦荞可可固体饮料,按重量份计算,用苦荞粉42-48份、可可粉12-18份、奶粉0-18份、一般甜味剂10-50份、高倍甜味剂0.01-1份、抗结剂1-2份、乳化剂0.1-3份、矿物质0.5-1.2份、维生素0.2-0.8份、营养添加剂1-11份、其他补充剂0-5份和食用香精香料0.03-0.07份制成。
前述的具有保健功能的苦荞可可固体饮料,所述苦荞粉为全麦苦荞粉或苦荞芯粉和苦荞皮层粉按重量比为0-90:100-10混合而成或由全麦苦荞粉加入苦荞麸皮粉或苦荞叶粉后得到或由苦荞芯粉和苦荞皮层粉混合后加入苦荞麸皮粉或苦荞叶粉后得到。
前述的具有保健功能的苦荞可可固体饮料,所述可可粉由按重量份计算的未碱化可可粉50-100份和碱化可可粉0-50份混合后过200目筛即得。
前述的具有保健功能的苦荞可可固体饮料,所述奶粉为脱脂奶粉或全脂奶粉或半脱脂奶粉;所述一般甜味剂为蔗糖、葡萄糖、果糖、麦芽糖、甜菊糖、木糖醇、三梨糖醇、甘露糖醇、赤藓糖醇、麦芽糖醇或乳糖醇中的一种以上;所述高倍甜味剂为糖精钠、甜蜜素、AK糖、阿斯巴甜、三氯蔗糖、阿力甜、纽甜、甘草甜素、甜菊苷、罗汉果甜苷或莱鲍迪苷A中的一种以上;所述的抗结剂为二氧化硅或磷酸三钙中的一种以上;所述乳化剂为黄原胶、卡拉胶、瓜尔胶、海藻酸钠、羧甲基纤维素钠、聚甘油脂肪酸脂或辛葵酸甘油脂的一种以上;所述的食用香精香料为香草醛。
前述的具有保健功能的苦荞可可固体饮料,所述的营养添加剂为卵磷脂、二十二碳六烯酸、二十碳五烯酸、亚麻酸、α-亚麻酸、γ-亚麻酸、共轭亚油酸、乙酰左旋肉碱、左旋肉碱、植物甾醇、植物甾醇脂、植物甾烷醇脂或磷脂酰丝氨酸中的一种以上。
前述的具有保健功能的苦荞可可固体饮料,所述营养添加剂为微胶囊粉。
前述的具有保健功能的苦荞可可固体饮料,所述的其他补充剂为银杏粉、银杏叶提取物、橄榄叶提取物、蛇足石杉提取物、蓝莓粉、蓝莓汁、刺梨粉、刺梨汁、菊粉、葛根粉、山药粉、山楂粉、天麻粉、三七粉、枸杞子粉、玛卡粉、灵芝粉、何首乌粉、丹参粉、西洋参粉、铁皮石斛粉、红景天粉、紫苏子粉、紫苏子油、亚麻子粉或亚麻子油种的一种以上;所述的矿物质为钙、铁、镁、磷、碘、锌、铜、锰、铬、钼、硒、氯化物、钾、镍、硅或钒中的一种以上;所述的维生素为维生素A、β胡萝卜素、维生素D3、维生素E、维生素K1、维生素B1、维生素B2、烟酰胺、维生素B6、生物素、维生素B12、泛酸、叶酸、维生素C、硫胺素、核黄素、尼克酸、叶黄素、番茄红素或α-硫辛酸中的一种以上。
一种前述的具有保健功能的苦荞可可固体饮料的制备方法,包括以下步骤:
(1)苦荞粉经双螺杆挤压膨化机膨化,得膨化后的苦荞粉;
(2)膨化后的苦荞粉粉碎至粒度为小于180um。
(3)将高倍甜味剂、抗结剂、乳化剂、矿物质、维生素、营养添加剂、其他补充剂和香精香料混合后,得预混粉;
(4)一般甜味剂粉碎后过60目筛;
(5)将粉碎好的苦荞粉、可可粉、奶粉、过60目筛后的一般甜味剂粉和预混粉混合后,干燥至含水率小于7%,得成品粉;
(6)成品粉经微波杀菌机杀菌,真空包装成袋,即得。
固体饮料具有运输方便、携带方便、容易保存、饮用方便、营养丰富等特点,粉状固体饮料含水率极低且采用真空包装,对各种营养物质的稳定具有保护作用。营养添加剂微胶囊粉性能稳定,可可粉固体饮料具有巧克力味,口感好。将苦荞与可可结合,加入本发明中的所述营养添加剂制作成巧克力味的低糖的固体饮料口感好,能起到降血糖、降血脂、调节血压的作用,可用于防治心血管疾病、糖尿病、老年性痴呆等症。
有益效果:与现有技术相比,所诉饮料具有降血糖、降血脂、调节血压、清除超氧自由基、抗氧化、提高记忆力、认知力、学习能力、提高免疫力、抗肿瘤的功效。可用于防治老年性痴呆,糖尿病等症。
治疗实例:
龙××,男,63岁,经贵州省人民医院检查血脂,血压偏高,后食用本发明产品2000mL,血压,血脂恢复正常。
刘××,男,40岁,经贵州省人民医院检查血压,血糖偏高,后食用本发明产品2000mL,血压,血糖恢复正常。
张××,女,45岁,经贵阳市第一人民医院检查血压,血糖偏高,后食用本发明产品2000mL,血压,血糖恢复正常。
李××,女,43岁,经贵阳市第一人民医院检查血压,血糖偏高,后食用本发明产品2000mL,血压,血糖恢复正常。
具体实施方式
本发明不受以下各种实施方式的限制。
实施例1:
固体饮料配方:苦荞芯粉23.4kg、苦荞皮层粉23.4kg、未碱化可可粉15.6kg、脱脂奶粉15.6kg、赤藓糖醇19.9kg、三氯蔗糖0.05kg、磷酸三钙1.5kg、辛葵酸甘油脂0.5kg、矿物质1kg、维生素0.6kg、卵磷脂3.75kg、二十二碳六烯酸0.625kg、二十碳五烯酸0.5kg、植物甾醇脂2kg和香草醛0.05kg。
固体饮料的制作方法,具体包括以下步骤:
(1)将苦荞心粉和苦荞皮层粉经混合机混合后,得苦荞混合粉;
(2)苦荞混合粉经双螺杆挤压膨化机膨化;
(3)膨化后的苦荞粉经气流超微粉碎机粉碎至粒度为小于180um。
(4)将赤藓糖醇、磷酸三钙、辛葵酸甘油脂、矿物质、维生素、卵磷脂、二十二碳六烯酸、二十碳五烯酸、植物甾醇脂和香草醛混合后,得预混粉;
(5)三氯蔗糖碎后过60目筛;
(6)将粉碎好的苦荞粉、可可粉、奶粉、过60目筛后的三氯蔗糖粉和预混粉混合后,干燥至含水率小于7%,得成品粉;
(7)成品粉经微波杀菌机杀菌,真空包装成袋,即得。
用法用量:取固体饮料40g,加160ml温水冲调。
实施例2:
固体饮料配方:苦荞芯粉23.4kg、苦荞皮层粉23.4kg、未碱化可可粉15.6kg、脱脂奶粉15.6kg、赤藓糖醇19.9kg、三氯蔗糖0.05kg、磷酸三钙1.5kg、辛葵酸甘油脂0.5kg、矿物质1kg、维生素0.6kg、卵磷脂3.75kg、二十二碳六烯酸0.625kg、二十碳五烯酸0.5kg、植物甾醇脂2kg、磷脂酰丝氨酸0.75kg和香草醛0.05kg。
固体饮料的制作方法,具体包括以下步骤:
(1)将苦荞心粉和苦荞皮层粉经混合机混合后,得苦荞混合粉;
(2)苦荞混合粉经双螺杆挤压膨化机膨化;
(3)膨化后的苦荞粉经气流超微粉碎机粉碎至粒度为小于180um。
(4)将赤藓糖醇、磷酸三钙、辛葵酸甘油脂、矿物质、维生素、卵磷脂、二十二碳六烯酸(DHA)、二十碳五烯酸(EPA)、植物甾醇脂、磷脂酰丝氨酸和香草醛混合后,得预混粉;
(5)三氯蔗糖碎后过60目筛;
(6)将粉碎好的苦荞粉、可可粉、奶粉、过60目筛后的三氯蔗糖粉和预混粉混合后,干燥至含水率小于7%,得成品粉;
(7)成品粉经微波杀菌机杀菌,真空包装成袋,即得。
用法用量:取固体饮料40g,加160ml温水冲调。
实施例3:
固体饮料配方:苦荞芯粉23.4kg、苦荞皮层粉23.4kg、未碱化可可粉15.6kg、脱脂奶粉15.6kg、赤藓糖醇19.9kg、三氯蔗糖0.05kg、磷酸三钙1.5kg、辛葵酸甘油脂0.5kg、矿物质1kg、维生素0.6kg、卵磷脂3.75kg、二十二碳六烯酸0.625kg、二十碳五烯酸0.5kg、植物甾醇脂2kg、磷脂酰丝氨酸0.75kg、共轭亚油酸3.75kg和香草醛0.05kg。
固体饮料的制作方法,具体包括以下步骤:
(1)将苦荞心粉和苦荞皮层粉经混合机混合后,得苦荞混合粉;
(2)苦荞混合粉经双螺杆挤压膨化机膨化;
(3)膨化后的苦荞粉经气流超微粉碎机粉碎至粒度为小于180um。
(4)将赤藓糖醇、磷酸三钙、辛葵酸甘油脂、矿物质、维生素、卵磷脂、二十二碳六烯酸(DHA)、二十碳五烯酸(EPA)、植物甾醇脂、磷脂酰丝氨酸、共轭亚油酸和香草醛混合后,得预混粉;
(5)三氯蔗糖碎后过60目筛;
(6)将粉碎好的苦荞粉、可可粉、奶粉、过60目筛后的三氯蔗糖粉和预混粉混合后,干燥至含水率小于7%,得成品粉;
(7)成品粉经微波杀菌机杀菌,真空包装成袋,即得。
用法用量:取固体饮料40g,加160ml温水冲调。
Claims (10)
1.一种具有保健功能的苦荞可可固体饮料,其特征在于:按照重量份计算,用苦荞粉20-60份、可可粉10-50份、奶粉0-30份、一般甜味剂10-50份、高倍甜味剂0.01-5份、抗结剂0.5-4份、乳化剂0.05-7份、矿物质0.1-2份、维生素0.2-1.5份、营养添加剂1-13份、其他补充剂0-8份和食用香精香料0.01-0.1份制成。
2.如权利要求1所述的具有保健功能的苦荞可可固体饮料,其特征在于:按重量份计算,用苦荞粉30-50份、可可粉10-40份、奶粉0-20份、一般甜味剂10-50份、高倍甜味剂0.01-3份、抗结剂1-3份、乳化剂0.05-4份、矿物质0.3-1.5份、维生素0.2-1.0份、营养添加剂1-11份、其他补充剂0-7份和食用香精香料0.03-0.07份制成。
3.如权利要求2所述的具有保健功能的苦荞可可固体饮料,其特征在于:按重量份计算,用苦荞粉42-48份、可可粉12-18份、奶粉0-18份、一般甜味剂10-50份、高倍甜味剂0.01-1份、抗结剂1-2份、乳化剂0.1-3份、矿物质0.5-1.2份、维生素0.2-0.8份、营养添加剂1-11份、其他补充剂0-5份和食用香精香料0.03-0.07份制成。
4.如权利要求1-3中任一项所述的具有保健功能的苦荞可可固体饮料,其特征在于:所述苦荞粉为全麦苦荞粉;或苦荞芯粉和苦荞皮层粉按重量比为0-90:100-10混合而成;或由全麦苦荞粉加入苦荞麸皮粉或苦荞叶粉后得到;或由苦荞芯粉和苦荞皮层粉混合后加入苦荞麸皮粉或苦荞叶粉后得到。
5.如权利要求1-3中任一项所述的具有保健功能的苦荞可可固体饮料,其特征在于:所述可可粉由按重量份计算的未碱化可可粉50-100份和碱化可可粉0-50份混合后过200目筛即得。
6.如权利要求1-3中任一项所述的具有保健功能的苦荞可可固体饮料,其特征在于:所述奶粉为脱脂奶粉或全脂奶粉或半脱脂奶粉;所述一般甜味剂为蔗糖、葡萄糖、果糖、麦芽糖、甜菊糖、木糖醇、三梨糖醇、甘露糖醇、赤藓糖醇、麦芽糖醇或乳糖醇中的一种以上;所述高倍甜味剂为糖精钠、甜蜜素、AK糖、阿斯巴甜、三氯蔗糖、阿力甜、纽甜、甘草甜素、甜菊苷、罗汉果甜苷或莱鲍迪苷A中的一种以上;所述的抗结剂为二氧化硅或磷酸三钙中的一种以上;所述乳化剂为黄原胶、卡拉胶、瓜尔胶、海藻酸钠、羧甲基纤维素钠、聚甘油脂肪酸脂或辛葵酸甘油脂中的一种以上;所述的食用香精香料为香草醛。
7.如权利要求1-3中任一项所述的具有保健功能的苦荞可可固体饮料,其特征在于:所述的营养添加剂为卵磷脂、二十二碳六烯酸、二十碳五烯酸、亚麻酸、α-亚麻酸、γ-亚麻酸、共轭亚油酸、乙酰左旋肉碱、左旋肉碱、植物甾醇、植物甾醇脂、植物甾烷醇脂或磷脂酰丝氨酸中的一种以上。
8.如权利要求1-3中任一项所述的具有保健功能的苦荞可可固体饮料,其特征在于:所述营养添加剂为微胶囊粉。
9.如权利要求1-3中任一项所述的具有保健功能的苦荞可可固体饮料,其特征在:所述的其他补充剂为银杏粉、银杏叶提取物、橄榄叶提取物、蛇足石杉提取物、蓝莓粉、蓝莓汁、刺梨粉、刺梨汁、菊粉、葛根粉、山药粉、山楂粉、天麻粉、三七粉、枸杞子粉、玛卡粉、灵芝粉、何首乌粉、丹参粉、西洋参粉、铁皮石斛粉、红景天粉、紫苏子粉、紫苏子油、亚麻子粉或亚麻子油种的一种以上;所述的矿物质为钙、铁、镁、磷、碘、锌、铜、锰、铬、钼、硒、氯化物、钾、镍、硅或钒中的一种以上;所述的维生素为维生素A、β胡萝卜素、维生素D3、维生素E、维生素K1、维生素B1、维生素B2、烟酰胺、维生素B6、生物素、维生素B12、泛酸、叶酸、维生素C、硫胺素、核黄素、尼克酸、叶黄素、番茄红素或α-硫辛酸中的一种以上。
10.一种如权利要求1-9中的任一项所述的具有保健功能的苦荞可可固体饮料的制备方法,其特征在于:包括以下步骤:
(1)苦荞粉经双螺杆挤压膨化机膨化,得膨化后的苦荞粉;
(2)膨化后的苦荞粉粉碎至粒度为小于180um;
(3)将高倍甜味剂、抗结剂、乳化剂、矿物质、维生素、营养添加剂、其他补充剂和香精香料混合后,得预混粉;
(4)一般甜味剂粉碎后过60目筛;
(5)将粉碎好的苦荞粉、可可粉、奶粉、过60目筛后的一般甜味剂粉和预混粉混合后,干燥至含水率小于7%,得成品粉;
(6)成品粉经微波杀菌机杀菌,真空包装成袋,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610848409.8A CN106261442A (zh) | 2016-09-26 | 2016-09-26 | 一种具有保健功能的苦荞可可固体饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610848409.8A CN106261442A (zh) | 2016-09-26 | 2016-09-26 | 一种具有保健功能的苦荞可可固体饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106261442A true CN106261442A (zh) | 2017-01-04 |
Family
ID=57714908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610848409.8A Pending CN106261442A (zh) | 2016-09-26 | 2016-09-26 | 一种具有保健功能的苦荞可可固体饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106261442A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109041630A (zh) * | 2018-06-26 | 2018-12-21 | 贵州来福农业科技有限责任公司 | 一种降血糖刺梨苦荞苗口服液及其制备方法 |
CN113558107A (zh) * | 2021-07-30 | 2021-10-29 | 山西振东五和健康科技股份有限公司 | 一种益智健脑的固体饮料及其制备方法 |
CN115281249A (zh) * | 2021-05-28 | 2022-11-04 | 王建波 | 一种巴旦木粉冲剂及其制作方法 |
CN116616359A (zh) * | 2023-05-30 | 2023-08-22 | 海南健泰生物科技有限公司 | 减肥苦荞茶及其制备方法 |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1077851A (zh) * | 1993-05-07 | 1993-11-03 | 莫仁正 | 低糖果脯和凉果生产新技术 |
CN1384185A (zh) * | 2001-05-08 | 2002-12-11 | 郑万炎 | 无糖果酒饮料及其制造方法 |
CN1868343A (zh) * | 2006-05-23 | 2006-11-29 | 大连础明生物科技有限公司 | 富含全价动物骨粉的饮料 |
CN101317684A (zh) * | 2007-06-08 | 2008-12-10 | 张文彪 | 一种固体饮料及制作方法 |
CN101433319A (zh) * | 2007-11-15 | 2009-05-20 | 许学芹 | 一种均衡营养保健食品 |
CN101623067A (zh) * | 2009-08-01 | 2010-01-13 | 胡志伟 | 带面皮的果味糕点 |
CN102349624A (zh) * | 2011-11-01 | 2012-02-15 | 中国农业大学 | 一种挤压膨化纤维食品及其制备的方法 |
CN103478261A (zh) * | 2013-08-26 | 2014-01-01 | 黑龙江省乳品工业技术开发中心 | 一种婴幼儿配方奶粉 |
CN103503996A (zh) * | 2012-06-18 | 2014-01-15 | 河北三元食品有限公司 | 一种品质稳定的养心奶制品及制备方法 |
CN103876152A (zh) * | 2014-04-15 | 2014-06-25 | 吉林农业大学 | 玉米活力素及其生产方法 |
CN104000066A (zh) * | 2013-12-09 | 2014-08-27 | 胡安然 | 一种调理肥胖的膳食 |
CN104855979A (zh) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | 降血脂非全营养配方食品 |
CN105163604A (zh) * | 2013-03-14 | 2015-12-16 | 泰特&莱尔组分美国公司 | 含纤维的碳水化合物组合物 |
CN105394182A (zh) * | 2015-10-27 | 2016-03-16 | 江西美庐乳业集团有限公司 | 一种具有降血糖功效及促进心脑血管健康的营养包 |
CN105707637A (zh) * | 2014-12-03 | 2016-06-29 | 河北以岭医药研究院有限公司 | 一种降糖固体饮料及其制备方法 |
CN105831570A (zh) * | 2016-04-13 | 2016-08-10 | 华北电力大学(保定) | 辅助降胆固醇的八宝粥 |
-
2016
- 2016-09-26 CN CN201610848409.8A patent/CN106261442A/zh active Pending
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1077851A (zh) * | 1993-05-07 | 1993-11-03 | 莫仁正 | 低糖果脯和凉果生产新技术 |
CN1384185A (zh) * | 2001-05-08 | 2002-12-11 | 郑万炎 | 无糖果酒饮料及其制造方法 |
CN1868343A (zh) * | 2006-05-23 | 2006-11-29 | 大连础明生物科技有限公司 | 富含全价动物骨粉的饮料 |
CN101317684A (zh) * | 2007-06-08 | 2008-12-10 | 张文彪 | 一种固体饮料及制作方法 |
CN101433319A (zh) * | 2007-11-15 | 2009-05-20 | 许学芹 | 一种均衡营养保健食品 |
CN101623067A (zh) * | 2009-08-01 | 2010-01-13 | 胡志伟 | 带面皮的果味糕点 |
CN102349624A (zh) * | 2011-11-01 | 2012-02-15 | 中国农业大学 | 一种挤压膨化纤维食品及其制备的方法 |
CN103503996A (zh) * | 2012-06-18 | 2014-01-15 | 河北三元食品有限公司 | 一种品质稳定的养心奶制品及制备方法 |
CN105163604A (zh) * | 2013-03-14 | 2015-12-16 | 泰特&莱尔组分美国公司 | 含纤维的碳水化合物组合物 |
CN103478261A (zh) * | 2013-08-26 | 2014-01-01 | 黑龙江省乳品工业技术开发中心 | 一种婴幼儿配方奶粉 |
CN104000066A (zh) * | 2013-12-09 | 2014-08-27 | 胡安然 | 一种调理肥胖的膳食 |
CN103876152A (zh) * | 2014-04-15 | 2014-06-25 | 吉林农业大学 | 玉米活力素及其生产方法 |
CN105707637A (zh) * | 2014-12-03 | 2016-06-29 | 河北以岭医药研究院有限公司 | 一种降糖固体饮料及其制备方法 |
CN104855979A (zh) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | 降血脂非全营养配方食品 |
CN105394182A (zh) * | 2015-10-27 | 2016-03-16 | 江西美庐乳业集团有限公司 | 一种具有降血糖功效及促进心脑血管健康的营养包 |
CN105831570A (zh) * | 2016-04-13 | 2016-08-10 | 华北电力大学(保定) | 辅助降胆固醇的八宝粥 |
Non-Patent Citations (1)
Title |
---|
肖诗明: "苦荞麦粉的挤压膨化特性的初步研究", 《西昌农业高等专科学校学报》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109041630A (zh) * | 2018-06-26 | 2018-12-21 | 贵州来福农业科技有限责任公司 | 一种降血糖刺梨苦荞苗口服液及其制备方法 |
CN115281249A (zh) * | 2021-05-28 | 2022-11-04 | 王建波 | 一种巴旦木粉冲剂及其制作方法 |
CN113558107A (zh) * | 2021-07-30 | 2021-10-29 | 山西振东五和健康科技股份有限公司 | 一种益智健脑的固体饮料及其制备方法 |
CN116616359A (zh) * | 2023-05-30 | 2023-08-22 | 海南健泰生物科技有限公司 | 减肥苦荞茶及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106072573A (zh) | 一种适用于老年肌肉衰减症食用的特膳食品 | |
CN106858620A (zh) | 一种贫血专用型临床营养配方及其制备方法 | |
CN109123643A (zh) | 一种谷物代餐球的制备方法 | |
US20230132388A9 (en) | Intact Pea Protein-Based Nutrient Composition | |
CN102511869B (zh) | 红枣生姜浓浆 | |
CN101190027A (zh) | 卡拉胶冻补充剂及其制备方法 | |
CN106261442A (zh) | 一种具有保健功能的苦荞可可固体饮料及其制备方法 | |
JP2021524755A (ja) | 加水分解されたエンドウマメタンパク質ベースの栄養組成物 | |
CN108719984B (zh) | 一种针对痛风人群的代餐营养棒及其制备方法 | |
CN102038260B (zh) | 中药解酒保健饮料及其制备方法 | |
CN107136511A (zh) | 一种促进脑神经发育的牡丹籽油组合物、牡丹籽油软胶囊及其制备方法 | |
CN106174474A (zh) | 一种适用于心脑血管疾病患者食用的特膳食品 | |
CN107616490A (zh) | 一种儿童术后专用型临床营养配方及其制备方法 | |
CN107440121A (zh) | 一种儿童单纯性肥胖专用型临床营养配方及其制备方法 | |
CN109619249A (zh) | 一种藻油dha加锌凝胶糖果及其制备方法 | |
CN108669540A (zh) | 脑卒中专用型临床营养配方及其制备方法 | |
CN105380271A (zh) | 无添加剂全籽粒绿豆复合营养粉及其生产方法 | |
CN104664370A (zh) | 一种亚麻咀嚼片 | |
CN107455625A (zh) | 一种具有抗疲劳减肥功能的植物营养素饮料及其制备工艺 | |
CN107094974A (zh) | 一种黑枸杞保健糖果及其制备方法 | |
CN108703365A (zh) | 蛋白质过敏专用型临床营养配方及其制备方法 | |
CN107440102A (zh) | 一种更年期女性专用型临床营养配方及其制备方法 | |
WO2023213325A1 (zh) | 一种超高纯度二十八烷醇-黄酮复合去氘水组合协同精制的高能饮料及其制备方法 | |
CN113170844A (zh) | 一种蔬果纤维营养饮料 | |
KR101875896B1 (ko) | 말뼈와 산호를 주성분으로 포함하는 건강보조식품 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170104 |
|
RJ01 | Rejection of invention patent application after publication |